Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04541719Phase 2Withdrawn
Phase 2, randomised, open-label trial of remifentanil in labor pain (2 arms), sponsored by Mansoura University. Primary endpoint: Overall patient's satisfaction. Planned start Apr 2017; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04541719.